title: Peptidomimetic HIV protease inhibitors: phosphate prodrugs with improved biological activities.
authors.affiliation: Cancer & Infectious Diseases Research, Upjohn Company, Kalamazoo, Michigan 49001.
authors.forename: K T
authors.initials: KT
authors.lastname: Chong
authors.forename: M J
authors.initials: MJ
authors.lastname: Ruwart
authors.forename: R R
authors.initials: RR
authors.lastname: Hinshaw
authors.forename: K F
authors.initials: KF
authors.lastname: Wilkinson
authors.forename: B D
authors.initials: BD
authors.lastname: Rush
authors.forename: M F
authors.initials: MF
authors.lastname: Yancey
authors.forename: J W
authors.initials: JW
authors.lastname: Strohbach
authors.forename: S
authors.initials: S
authors.lastname: Thaisrivongs
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000138:chemical synthesis* / Q000493:pharmacokinetics / Q000494:pharmacology; D017320:HIV Protease Inhibitors / Q000138:chemical synthesis* / Q000494:pharmacology; D006207:Half-Life; D006801:Humans; D008297:Male; D009943:Organophosphorus Compounds / Q000138:chemical synthesis* / Q000493:pharmacokinetics / Q000494:pharmacology; D011355:Prodrugs / Q000138:chemical synthesis*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013329:Structure-Activity Relationship
chemical_list: D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D009943:Organophosphorus Compounds; D011355:Prodrugs